+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID07059546

Study of Adrenomedullin Effects on Persistent Post-Traumatic Headache After Mild Traumatic Brain Injury

Led by Danish Headache Center · Updated on 2025-07-30

21

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether adrenomedullin, a neuropeptide involved in headache development, can trigger migraine-like headaches in people with persistent post-traumatic headache PTH caused by mild traumatic brain injury mTBI. This study focuses on individuals who have experienced PTH with migraine-like symptoms for at least 12 months and aims to better understand the role of adrenomedullin in headache mechanisms. The study involves a randomized, double-blind, placebo-controlled, two-way crossover design where participants receive intravenous infusions of either adrenomedullin or a placebo isotonic saline. Each infusion consists of 20 mL delivered continuously over 20 minutes. Participants will receive both treatments in separate sessions to compare the effects on headache induction. During the trial, researchers will monitor participants for the incidence of migraine-like headaches and measure headache intensity over 12 hours following infusion. Participants will undergo assessments related to headache features and intensity, with careful observation to ensure safety. The study will last through the infusion and follow-up periods, with data collection focused on understanding headache responses to the interventions.

CONDITIONS

Brief Title

Hypersensitivity to Adrenomedullin in Post-Traumatic Headache

Research Team

H

Haidar Al-Khazali, MD

H

Hakan Ashina, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here